Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment?

Eur J Dermatol. 2019 Feb 1;29(1):101-102. doi: 10.1684/ejd.2018.3454.

¹ University Hospital, Pulmonology Department, 54000 Nancy, France, University of Lorraine, EA 3450 DevAH, Development, Adaptation, Cardio-Respiratory Regulations and Motor Control, 54000 Nancy, France.
² University Hospital, Dermatology-Allergology Department, 54000 Nancy, France.
³ Pasteur Institute, Center for Innovation and Technological Research, 75000 Paris, France, Assistance Publique-Hôpitaux de Paris (AP-HP), Armand-Trousseau Children Hospital, Biochemistry Laboratory, Allergy and Environment Team, 75000 Paris, France.
⁴ Assistance Publique-Hôpitaux de Paris (AP-HP), Armand-Trousseau Children Hospital, Biochemistry Laboratory, Allergy and Environment Team, 75000 Paris, France.
⁵ University Hospital, Dermatology-Allergology Department, 54000 Nancy, France, University of Lorraine, 54000 Nancy, France.

No abstract available

Publication types